Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/31474
Full metadata record
DC FieldValue
dc.contributor.authorFilardy, Alessandra Almeida
dc.contributor.authorPinto, Kamila Guimarães
dc.contributor.authorNunes, Marise Pinheiro
dc.contributor.authorZukeram, Ketiuce
dc.contributor.authorFliess, Lara
dc.contributor.authorPereira, Ludimila
dc.contributor.authorNascimento, Danielle Oliveira
dc.contributor.authorConde, Luciana
dc.contributor.authorMorrot, Alexandre
dc.date.accessioned2019-02-07T12:59:38Z
dc.date.available2019-02-07T12:59:38Z
dc.date.issued2018
dc.identifier.citationFILARDY, Alessandra Almeida et al. Human Kinetoplastid Protozoan Infections: Where are we going next?. Frontiers in Immunology, v. 9, p. 1-7, July 2018.
dc.identifier.issn1664-3224
dc.identifier.urihttps://www.arca.fiocruz.br/handle/icict/31474
dc.language.isoeng
dc.publisherFrontiers Media
dc.rightsopen access
dc.subject.otherTrypanosoma cruzi
dc.subject.otherLeishmania
dc.subject.otherTrypanosoma brucei
dc.subject.otherProtozoários kinetoplastid
dc.subject.otherInfecção parasitária
dc.titleHuman Kinetoplastid Protozoan Infections: Where Are We Going Next?
dc.typeArticle
dc.identifier.doi10.3389/fimmu.2018.01493
dc.description.abstractenKinetoplastida trypanosomatidae microorganisms are protozoan parasites exhibiting a developmental stage in the gut of insect vectors and tissues of vertebrate hosts. During the vertebrate infective stages, these parasites alter the differential expression of virulence genes, modifying their biological and antigenic properties in order to subvert the host protective immune responses and establish a persistent infection. One of the hallmarks of kinetoplastid parasites is their evasion mechanisms from host immunity, leading to disease chronification. The diseases caused by kinetoplastid parasites are neglected by the global expenditures in research and development, affecting millions of individuals in the low and middle-income countries located mainly in the tropical and subtropical regions. However, investments made by public and private initiatives have over the past decade leveraged important lines of intervention that if well-integrated to health care programs will likely accelerate disease control initiatives. This review summarizes recent advances in public health care principles, including new drug discoveries and their rational use with chemotherapeutic vaccines, and the implementation of control efforts to spatially mapping the kinetoplastid infections through monitoring of infected individuals in epidemic areas. These approaches should bring us the means to track genetic variation of parasites and drug resistance, integrating this knowledge into effective stewardship programs to prevent vector-borne kinetoplastid infections in areas at risk of disease spreading.
dc.creator.affilliationUniversidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Microbiologia Prof. Paulo de Góes. Departamento de Imunologia. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationUniversidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Microbiologia Prof. Paulo de Góes. Departamento de Imunologia. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationUniversidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Microbiologia Prof. Paulo de Góes. Departamento de Imunologia. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationUniversidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Microbiologia Prof. Paulo de Góes. Departamento de Imunologia. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationUniversidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Microbiologia Prof. Paulo de Góes. Departamento de Imunologia. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationUniversidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Microbiologia Prof. Paulo de Góes. Departamento de Imunologia. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationUniversidade Federal do Rio de Janeiro. Centro de Ciências da Saúde. Instituto de Microbiologia Prof. Paulo de Góes. Departamento de Imunologia. Rio de Janeiro, RJ, Brasil.
dc.creator.affilliationFundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Faculdade de Medicina. Centro de Pesquisa em Tuberculose. Rio de Janeiro, RJ, Brasil.
dc.subject.enParasitic infection
dc.subject.enKinetoplastid protozoans
dc.subject.enTrypanosoma cruzi
dc.subject.enLeishmania
dc.subject.enTrypanosoma brucei
Appears in Collections:IOC - Artigos de Periódicos

Files in This Item:
File Description SizeFormat 
marisenunes_alexandremorrto_etal_IOC_2018.pdf898.99 kBAdobe PDFView/Open



FacebookTwitterDeliciousLinkedInGoogle BookmarksBibTex Format mendeley Endnote DiggMySpace

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.